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Various cytokines have in the past been detected in human 
skin. Among these, the neutrophil-activating peptide NAP-
1/IL-8 is a potent 8-kD proinflammatory peptide that has 
been purified from psoriatic scales. Its chemotactic activity on 
human neutrophils, as well as its presence in psoriatic scales, 
may relate to a role in this disease. In the present study, the 
tissue distribution of the peptide was examined immunohis-
tochemically using two monoclonal antibodies (52E8, 46E5) 
recently produced and characterized in our laboratory. 
Immunoreactivity was detected in both normal and psor-
iatic skin, resulting in uniform suprabasal keratinocyte stain-
R ecent work on epidermal cytokines has revealed the presence of several biologically highly active peptides that play an important role in the regulation of im-mune-related processes (1- 3]. In scale material de-rived from patients with psoriasis vulgaris, we were 
able to detect several potent polypeptide chemoattractants for 
human neutrophils (4,5], among them the neutrophil-activating 
peptide NAP-1/IL-8. . . 
This peptide has recently been substantially charactenzed ~oth 
functionally and biochemically [8 - 15]. As demonstrated by vanous 
authors including our own group, lipopolysaccharide (LPS) or mi-
togen-stimulated mononuclear cells or isolated monocytes [8-14], 
T -lymphocyte preparations (16,17], endothelial cells (18], as well as 
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ing in normal skin with 52E8 and of all keratinocytes with 
46E5. Immunoreactivity in psoriasis correlated to the inflam-
matory tissue reaction, varying from uniform absence in 
highly active psoriasis to focally weak staining in plaque type 
psoriasis. Cells of the acrosyringium and hair follicles were 
always positive and were unaffected by the inflammatory 
activity. Epidermal immunoreactivity detected in this study 
may be associated with closely related peptides of the IL8 
family or with truncated or extended forms ofNAP-1/IL-8. 
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dermal fibroblasts [19 -21], are able to produce NAP-1/IL-8 or 
variants thereof. Furthermore, its chemotactic activity is not re-
stricted to human neutrophilic granulocytes, but, as has been shown 
recently, includes lymphocytes as well [22]. This led to the proposal 
of interleukin-8 as a comprehensive name for the different charac-
teristics of this factor [23). 
Similar to several other well-defined neutrophil activators, NAP-
1/IL-8 is able to stimulate human neutrophil arachidonate-5-lipox-
ygenase and the release of L TB4 (24,25]. thus enhancing inflamma-
tory processes. The involvement of neutrophils, as evident by the 
histology of psoriasis (6,7], further implies a major role for NAP-1 / 
IL-8 in this skin disease. We have produced a number of monoclo-
nal antibodies (MoAb) against NAP-1/IL-8 (26], two of which we 
used in this study to identify immunoreactivity of NAP-1 /IL-8 in 
normal and psoriatic skin. Surprisingly, a differential expression of 
NAP-1/IL-8 immunoreactivity was found not only in diseased, but 
also in normal skin. 
MATERIALS AND METHODS 
Biopsies Ten patients with psoriasis vulgaris were informed and 
agreed to participate in this study by written consent. The diagnosis 
was established on clinicaJ grounds and histopathologically. The 
patients received neither local nor systemic treatment for at least 2 
months prior to the study. Six-millimeter punch biopsies were 
taken from lesional skin under local anesthesia (1 % Meaverin). In 
three patients, uninvolved skin was biopsied as well. Normal skin 
was obtained from patients undergoing plastic reconstructive sur-
gery under local anesthesia in our hospital. The specimens were 
snap frozen in liguid nitrogen and stored at -70°C until further 
processing. 
Monoclonal Antibodies Against NAP-1/IL-8 (52E8, 46E5) 
The monoclonal antibodies against NAP-1/IL-8, 52E8 and 
46E5, were produced in our laboratory as described earlier (26]. 
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Briefly, immune splenocytes o~ Balb/c mice that had bee~ immu-
nized with HPLC-pm;tfi.ed anttgen [14,17] were fused wtth Ag8-
X63-653 myeloma cells. Positive hybridomas were selected by solid 
phase enzyme-linked immunosorbent assay (ELISA), initially 
cloned at least twice, andre-cloned at regular intervals. The mono-
clonal antibodies (MoAb) used in this study differ in respect to 
isorype (52E8 IgG 1 , 46E5 IgG2. ) , isoelectric focusing pattern, and 
epitope recognition, as determined by sandwich ELISA. Hybrid-
omas were grown in RP MI 1640 containing 5-10% fetal calf 
serum. Culture supernatants were centrifuged and dilutions appro-
priate for immunohistology were determined using the staining 
procedure described below. 
Immunolabeling Procedure Four-6-J.Lm cryostat sections 
were fixed with acetone for 10 min and stained with the standard 
indirect immunoperoxidase technique: culture supernatants of hy-
bridoma clones 52E8 or 46E5 were incubated at appropriate dilu-
tion in 0.01 m Tris-HCI, pH7.4 containing 1% (wjv) bovine serum 
albumin for 30 min and the slides were then washed in Tris-buf-
fered saline. Negative controls were incubated with dilution buffer 
only. This was followed by secondary and tertiary peroxidase-cou-
pled antibodies (rabbit anti-mouse I~G and goa~ anti-rabbit IgG, 
respectively, Dak?~atts, Denmark) , dtluted 1: 15 111 phosphate-buf-
fered saline contammg 50% (v /v) human serum. The color reaction 
was performed with diaminobenzidine, 0.5 mgjml, in 0.5 mM Tris 
buffer, pH 7.6, containing 0.015% (v/v) H 20 2 , followed by coun-
terstaining with Mayer's Hemalum. The slides were finally 
mounted in Glycergel (Dakopatts) . 
RESULTS 
Staining with 52E8 Immunoreactivity with MoAb 52E8 in 
normal skin was present in suprabasal keratinocytes, most promi-
nently within the stratum spinosum but extending to the stratum 
corneum (Fig 1A). Similarly, keratinocyte layers of hair bulbs were 
positive. Intracellular staining could be seen with a clustering 
around the nuclei (Fig. 1B). The basal cell layer, the dermis includ-
ing endothelial cells, and the few mononuclear cells present were 
negative. No staining could be seen in negative controls. 
In lesional psoriatic skin, three patterns of immunoreactivity 
could be observed. Firstly, a uniform staining of suprabasal keratino-
cytes extending to the stratum corneum was present in the speci-
mens, demonstrating slight inflammatory infiltrates (Fig 2A). The 
second pattern (Fig 2B) demonstrated totally absent or weak immu-
noreactivity in selected areas of the differentiating epidermis. This 
pattern was present in areas underlying parakeratotic horny layers 
(Fig 2B) and in areas with massive dermal infiltrates. The subcor-
neal cell layers below parakeratotic zones were generally immunore-
active, whereas within the parakeratosis itself there were only occa-
sional weakly stained epidermal cells in addition to positive 
infiltrating cells in and around Munro's rnicroabscesses (Fig 3). In 
orthokeratotic areas, on the other hand, suprabasal staining was 
prominent similar to the first pattern observed (Fig 2A). The ab-
sence of immunoreactivity in suprabasal keratinocytes over the full 
course of the epidermis represented a third pattern and this was 
noted in specimens with high inflammatory activity (Fig 2C). In 
contrast to the neighboring keratinocytes, acrosyringeal cells and 
hair follicles constantly demonstrated a high immunoreactivity (Fig 
2C, 4) . Uninvolved skin from psoriatic patients was stained in the 
same pattern as normal skin (data not shown). 
Staining with 46E5 In contrast to the reaction pattern seen in 
normal skin with 52E8, the MoAb 46E5 demonstrated marked 
staining of the basal cell layer in addition to suprabasal cell staining 
(Fig 5) . A polar distribution of the intracellular immunoreactivity 
within the basal cells, with emphasis on the dermal side, could be 
seen. In addition, the tips of the rete pegs were often only lightly 
stained. The keratinocytes, including cells of the stratum granulo-
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Figure 1. Immunoperoxidase staining of normal skin with MoAb 52£8; 
staining of suprabasal cell layers can be ~cen. A, magnification X450; B, 
X1000). . 
sum, were positive with intracellular immunoreactivity of differing 
intensity (Fig 5). In negative controls, no staining could be detected. 
A pattern similar to that seen in normal skin was produced in 
psoriatic skin (Fig 6). Interestingly, epidermal staining was weaker 
in areas above dermal infiltration, although characteristic distribu-
tion patterns, as described for 52E8, could not be observed. Capil-
lary endothelial cells and mononuclear infiltrating cells were only 
weakly stained. As with 52E8, uninvolved skin stained in the same 
pattern as normal skin (data not shown) . 
DISCUSSION 
In the present study, N AP-1 /IL-8 immunoreactivity was detected 
in normal and psoriatic epidermis using two different MoAb re-
cently produced and characterized in our laboratory [26,27). 
Previous work has shown that these two monoclonal anti-NAP-1/ 
IL-8 antibodies, which are called 46E5 and 52E8, react with differ-
ent epitopes on the native peptide [26]. Western blotting experi-
ments on cytokeratin preparations (provided by Dr. D. Breitkreutz, 
Deutsches Krebsforschungsinstitut, Heidelberg, FRG) demon-
strated, in contrast to anti-keratin antibodies, no reactivity of the 
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Figure 2. Immunoperoxidase staining of psoriatic skin with MoAb 52E8; 
three sta ining patterns can be observed depending on the inflammatory state: 
A, uniform staining of suprabasal keratinocyres in cases with sli ght inflam-
matory infiltration (magnification X200); B, focally weak or absent immu-
noreactivity in areas of overlying parakeratosis or dermal infiltration (mag-
nifica tion X IOO); C, absence of immunoreactivity over the fu ll course of 
epidermis in a speci men with high inflammatory activity (magnification 
X100). 
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Figure 3. lmmunoperoxidase staining of parakeratotic layers with MoAb 
52£8; infiltrating cells of Munro's microabsccsses arc positive (magnifica· 
tion X450). 
NAP-1/IL-8 MoAb (data not shown). Thus, a major component of 
keratinocytes bas been excluded as a source for the immunoreactiv· 
ity described here. 
The reaction patterns detected in normal epidermis, as well as in 
uninvolved skin, reveal marked differences between the two MoAb; 
they also show distinct differences between normal skin immunore· 
activity and the staining of lesional psoriatic epidermis. Using the 
MoAb 52E8, strong intracellular immunoreactivity could be de· 
tected in the suprabasal keratinocytes of normal skin. Whereas with 
this MoAb no antibody binding within the basal layer is seen, tht 
MoAb 46ES markedly stains the basal cells and, to a varying extent, 
suprabasal cells. 
A pattern similar to normal skin is noted in chronic plaque typt 
Figure 4. hnmunoperoxidase staining of acrosyringeal cells and hair fol\i 
cles within psoriatic tissue show distinct immunoreactivity adjacent tone~ 
tive neighboring keratincoytes (magnification X450). 
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Figure 5. Jmmunoperoxidase staining of normal skin using MoAb 46£5; 
staining of basal ce ll layer and suprabasal layers can be seen (magnification 
X450). 
psoriasis using 52E8. Howev~r, lesional skin from patients with 
(eruptive) recent onset of the d1sease shows focal absence of stammg 
in areas of dense inflammatory infiltration and parakeratosis. Thus, 
the expression of the 52E8 reactive antigen appears to be related to 
the disease activity and extent of cutaneous inflammation. Because 
immunoreactivity could constantly be detected in the non-in-
flammed skin, these findings suggest the release of NAP-1/IL-8 -
related (52E8 binding) antigen from the epidermal cytokine pool. 
Moreover, the absence of immunoreactivity as seen in the affected 
areas is strictly confined to the psoriatic keratinocytes. Neighboring 
cells of the intraepidermal eccrine sweat duct (acrosyringium), as 
well as cells of the outer root sheath of the hair follicles, retained full 
immunoreactivity, even in the immediate vicinity of completely 
negative psoriatic keratinocytes. This indicates a difference in the 
mechanism by which the antigen is released from psoriatic keratino-
cytes and sweat duct cells. The existence of different sets of recep-
tors could explain these observations. 
Infiltrating mononuclear cells and endothelial cells in the upper 
dermis were only weakly stained, and no difference in reactivity 
could be observed between normal and psoriatic skin. It is of interest 
that NAP-1/IL-8, as well as other closely related peptides, has been 
purified from both cell types [14, 18] and that these were detected by 
the MoAb [27] . 
Furthermore, NAP-1/IL-8 has been shown to share homologies 
with a number of recently detected peptides that possess proinflam-
matory and/ or growth-stimulating activities [8, 15,17 ,28) . These 
comprise peptides primarily produced by platelets, e.g., ,8-throm-
boglobulin [29) and platelet factor 4 [30), as well as connective 
tissue-activating peptide III (CTAP III [29]). In addition, a y inter-
feron-induced protein (IP 10), as described by Luster et al [31 ,32], 
and a peptide with melanoma growth stimulatory activity (MGSA), 
isolated and characterized by Richmond et al [33,34], demonstrate 
amino acid sequence homologies that could account for the immu-
noreactivity described here. Immunohistologic studies on human 
skin have been published for IP-10 [35) and MGSA [34), but show 
distinctly different staining patterns when compared to our results. 
Furthermore, both MoAb used in this study did not react with 
human skin-derived MGSA, which was purified in our laboratory 
and tested in ELISA and Western blot for immunoreactivity [27]. 
Finally, a further target for antibody binding could be truncated 
NAP-1/IL-8 peptides. Studying endothelial cell- [18] , and fibro-
blast-derived NAP-1/IL-8 [21), several truncated and extended 
forms were purified in our laboratory. These were shown to react 
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with the two MoAb used here [27]. According to the staining pat-
terns in normal and psoriatic skin, different antigens are detected by 
the antibodies. This could well be explained by the expression of 
different truncated forms or precursors ofNAP-1 /IL-8 within kera-
tinocytes, which show differential immunoreactivity. 
Obviously, both of the antigens share an epitope with genuine 
NAP-1/IL-8 as preincubation of the MoAb with the peptide abol-
ishes antibody binding in a dose-dependent manner (data not 
shown). Only the 52E8 reactive antigen is universely related to 
disease activity and may represent a molecule form to be secreted i n 
inflammatory processes. Interestingly, in human cultured keratino-
cytes NAP-1/IL-8 has been shown by Northern blot to be tran-
scribed only after maximal stimulation [19]. On the other hand, 
preliminary data from our own laboratory indicate that supernatants 
from stimulated human keratinocytes contain neutrophil activating 
peptides related to NAP-1/IL-8. This finding suggests the presence 
of a preformed peptide pool that is processed upon stimulation. 
In support of this, extracts obtained from normal human epider-
mis demonstrated strong immunoreactivity after HPLC chromatog-
raphy, whereas NAP-1/IL-8-related biologic activity was absent 
Figure 6. Immunoperoxidase staining of psoriatic skin using MoAb 46£5; 
A, magnification XlOO; lB, magnification X450). Staining of basal an.d 
suprabasal cells is less intense than in normal skin, with only one distinct 
pattern of more or less homogenous staining. 
30 STlCHERLlNG ET AL 
(author's unpublished observations). Work is in progress to charac-
terize these keratinocyte-derived peptides and to illustrate their sig-
nificance under pathologic conditions. 
We are grateful to Miss Anke Rose for her excellent technical assistance and to Mrs. 
lise Brandt for typing the manuscript. 
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